Skip to content
Search

Latest Stories

UK was too slow to act on COVID-19 initially: Keir Starmer

Britain was initially too slow to respond to the novel coronavirus outbreak and did not learn quickly enough from other countries, opposition Labour Party leader Keir Starmer said on Wednesday (15).

Prime minister Boris Johnson initially refrained from approving the stringent controls that other European leaders imposed but then closed down the country when projections showed a quarter of a million people could die in the UK.


So far, more than 12,000 people with COVID-19 have died in British hospitals, though new official data indicates the true death toll could be much larger.

"I think that some of the decisions made in the last few weeks were too slow and didn't learn quickly enough from other countries, let's not repeat that," Starmer told BBC Radio.

Starmer, a 57-year-old former prosecutor who won the leadership of the Labour Party earlier this month, is calling on the British government to publish its exit strategy from lockdown restrictions.

Governments around the world are grappling with how to reverse measures put in place to contain the outbreak and which are battering the global economy. Several European countries have announced plans or already begun to relax restrictions.

Starmer said mass testing was likely to play a big role in any exit strategy and the government needed to put the necessary planning, investment and infrastructure in place early.

Foreign minister Dominic Raab, who is deputising for Johnson while he recovers from COVID-19, said on Monday (13) he did not expect to make any changes to the restrictions for now. They are due to be reviewed on Thursday (16).

Starmer said Labour supported extending the measures in Britain but that to "maintain morale and hope", the public needed to have an idea of what is coming next.

"Overcoming this crisis requires taking the British public with you," Starmer said. "The government needs to be open and transparent... The silent pressures on communities across the country cannot be underestimated."

A British government source said all decisions would be guided by scientific advice and data.

"Talk of an exit strategy before we have reached the peak risks confusing the critical message that people need to stay at home in order to protect our NHS (National Health Service) and save lives," the source said.

The government promised on Wednesday to test all residents and employees of nursing homes who have COVID-19 symptoms after official data showed the death toll from the pandemic was far higher when the elderly in care were included.

(Reuters)

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less